CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-6
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG PER INJECTION (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide designed to stimulate the body's natural growth hormone (GH) release while enhancing appetite through ghrelin receptor activation. The 10 mg format by Peptide Hubs provides a high concentration suitable for extended-duration protocols in metabolic and recovery-focused research.
GHRP-6 binds to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary, triggering significant increases in GH secretion and hunger signals. This makes it highly valuable in preclinical models focused on muscle wasting, recovery from injury, appetite stimulation, and anabolic research. For detailed insights, review this NIH article on growth hormone secretagogues.
GHRP-6 is commonly studied in combination with CJC-1295 DAC to potentiate GH pulses, or GHK Basic to evaluate skin and tissue regeneration under GH influence.
Researchers often stack GHRP-6 with additional peptides for comprehensive anabolic and regenerative models:
GHRP-6 10 mg is offered strictly for **research purposes only**. It is not FDA-approved for human consumption. Although well-tolerated in research, some models show possible side effects like increased appetite, mild bloating, or transient prolactin elevation. It does not cause liver toxicity, aromatization, or androgenic side effects. For updates on its clinical relevance, visit ClinicalTrials.gov.
GHRP-6 10 mg is used in research to explore GH secretion, appetite stimulation, lean mass development, and muscle recovery in preclinical studies.
While both stimulate GH release, GHRP-6 produces a stronger appetite response than GHRP-2, making it more suitable for bulking or recovery-based research protocols.
Yes. GHRP-6 is frequently combined with CJC-1295 DAC to extend and amplify GH pulse effects, especially in studies targeting body composition and recovery.
No, GHRP-6 is not approved by the FDA and is sold for laboratory research use only. It should not be used in humans or animals outside research protocols.
Please log in to write GHRP-6 10 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: GHRP-6
FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: APPROXIMATELY 1-2 HOURS
DOSAGE: 100-300 MCG, 2-3 TIMES PER DAY
ACNE: LOW RISK
WATER RETENTION: LOW TO MODERATE RISK
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: NO RISK
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (r-hGH)
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 CARTRIDGE x 15 MG
ACTIVE HALF-LIFE: ~2–3 HOURS
DOSAGE: MEN 4-10 IU/DAY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MAY INCREASE VIA FLUID RETENTION
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: NONE
MANUFACTURER: NOVO NORDISK
CLASSIFICATION: GONADOTROPIN (LH RECEPTOR AGONIST)
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 LYOPHILIZED VIAL x 5000 IU + PROVIDED SOLVENT
ACTIVE HALF-LIFE: ~24–36 HOURS
DOSAGE: MEN 500-1000 IU
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MONITOR IF AT CV RISK
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: INDIRECT
MANUFACTURER: IBSA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA